## Abstract [α‐^11^C]Benzoyl chloride was synthesized and purified by normal phase HPLC. [^11^C]MK‐996 ([^11^C]__N__‐[[4′[(2‐ethyl‐5,7‐dimethyl‐3H‐imidazo [4,5‐b]pyridin‐3‐yl)methyl][1,1′‐biphenyl]‐2‐yl]sulfonyl]‐benzamide), a potent and selective ligand for the AT~1~ receptor, was prepared by __N_
In vitro phamacology of MK-996, a new potent and selective angiotensin II (AT1) receptor antagonist
✍ Scribed by Raymond S. L. Chang; Robert J. Bendesky; Tsing-B. Chen; Kristie A. Faust; Paul J. Kling; Stacey A. O'Malley; Elizabeth M. Naylor; Prasun K. Chakravarty; Arthur A. Patchett; William J. Greenlee; Bradley V. Clineschmidt; Victor J. Lotti
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 880 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract A reaction sequence suitable for the preparation of an analog of 2‐propyl‐1‐[2′‐(1H‐tetrazol‐5‐yl)[1,1′‐biphenyl]‐4‐yl]methyl‐4‐[2‐(trifluoroacetyl)‐1H‐pyrrol‐1‐yl]‐1H‐imidazole‐5‐carboxylic acid, with ^14^C at the methylene bridge was developed. The would‐be labeled fragment (12) was d
Combined liquid chromatography and electrospray mass spectrometry (LC/ESI-MS) and tandem mass spectrometry (MS/MS) were used for the characterization of the conjugated metabolites (glucuronides) of a new angiotensin I1 receptor antagonist, candesartan cilexetil (TCV-116; ( f )-l-(cyclohexyloxycarbon